Trials / Recruiting
RecruitingNCT04364503
Compliant Analysis of Patient Samples and Data
Use of Patient Samples and Corresponding Clinical Data for Research and Development Studies And/or Population-based Analysis
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Sequenom, Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.
Detailed description
Arm 1 - Remnant commercial samples and data that has been de-identified of personal health information in compliance with HIPAA may be used for R\&D studies or population-based analysis by LabCorp or affiliates. Arm 2 - Collection of samples and/or data from commercial test patients requiring follow-up or from subjects of scientific interest after informed consent is obtained.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Multiple interventions depending on diagnostic test being run. | Remnant samples and corresponding data from multiple diagnostic tests will be stored for future research and development. |
Timeline
- Start date
- 2018-03-17
- Primary completion
- 2030-03-17
- Completion
- 2030-08-15
- First posted
- 2020-04-28
- Last updated
- 2024-10-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04364503. Inclusion in this directory is not an endorsement.